How Gut Microbiota Impact Endothelial Cell Senescence

Recent research has revealed complex interactions between gut microbiota, metabolites, and endothelial cell senescence, highlighting both detrimental and protective effects of certain microbial products. This article examines findings from a multifaceted study that explored the underlying mechanisms driving endothelial cell aging in relation to gut microbiota.

Senescence in the Blood Vessels

Endothelial cells, which line the inner surfaces of blood vessels, play a crucial role in maintaining cardiovascular health. However, as individuals age, endothelial cells undergo senescence, characterized by a series of cellular changes that can lead to dysfunction and contribute to age-related cardiovascular diseases. A central focus of recent studies is understanding the molecular mechanisms driving these changes.

The Host-Microbial Connection

This research began by analyzing plasma metabolites in both aged (24-month-old) and young (3-month-old) mice. Aged mice exhibited increased levels of phenylacetic acid (PAA) and its derivative, phenylacetylglutamine (PAGln). This metabolic pathway demonstrates a shared responsibility between the host and its microbiome, wherein dietary phenylalanine is metabolized into PAA by microbial activity, and subsequently converted to PAGIn by the host.

The importance of this pathway in cardiovascular health cannot be understated, given previous associations between metabolites and serious conditions, such as:

The discovery of the bacterium Clostridium sp. ASF356, which showed a positive association with plasma PAA levels in aged mice, further illustrates the microbial influence on metabolic pathways that affect endothelial senescence. Similar patterns were observed in human cohorts, indicating a broader relevance of these findings.

Aging-Promoting Processes

To elaborate on the effects of microbial metabolites, the impact of Clostridium sp. ASF356 and PAA on aortic endothelial senescence was evaluated. Following the elimination of the gut microbiome with antibiotics, the colonization of mice with Clostridium sp. ASF356 resulted in increased levels of both PAA and PAGIn. Analysis of the endothelial cells revealed significant markers of senescence, suggesting a direct link between this bacterium and endothelial dysfunction.

Furthermore, treating human aortic endothelial cells with PAA confirmed that this metabolite induces senescence, as indicated by various biomarkers. The administration of senolytic agents, such as dasatinib and quercetin, reduced senescence markers and improved angiogenesis, reinforcing the therapeutic potential of targeting these pathways.

Stressing the Cells

Continuing the investigation, researchers sought to understand how PAA influences oxidative stress in endothelial cells, a known promoter of senescence. They discovered that exposure to PAA elevated mitochondrial production of reactive oxygen species (ROS), specifically hydrogen peroxide (H2O2), leading to alterations in cell metabolism and functionality akin to senescent cells.

The connection between PAA-induced oxidative stress and senescence was further elucidated by the identification of a cascade of molecular events triggered by ROS, including:

• Increased Interleukin-6 (IL-6) levels
• Upregulation of the Senescence-Associated Secretory Phenotype (SASP)
• Energy imbalances impacting vascular health

Fighting Microbes with Microbes

Aging also diminishes the diversity and functional capacity of the microbiome, resulting in decreased levels of beneficial short-chain fatty acids (SCFAs) such as acetate. This reduction contributes to the pathology of cardiovascular diseases. Remarkably, when PAA-exposed endothelial cells were treated with sodium acetate, significant improvements were observed in cellular proliferation, reduction of senescence markers, and mitochondrial function.

This highlights the potential for using acetate as a senomorphic agent, promoting healthier endothelial function while mitigating the adverse effects of microbial metabolites like PAA. These findings suggest a promising avenue for therapeutic intervention in age-associated vascular decline.

Potential Biomarkers and Therapeutic Approaches

The study suggests that microbes like Clostridium sp. ASF356 and metabolites such as PAA could serve as valuable biomarkers for assessing vascular aging. As Seyed Soheil Saeedi Saravi, the lead author, noted, “The aging process of the cardiovascular system can therefore be regulated via the microbiome.” This emphasizes the need for further exploration of these microbial influences on endothelial health.

Ultimately, this research not only elucidates the mechanisms behind microbiota-related vascular aging but also points to potential therapeutic strategies that could improve cardiovascular outcomes in aging populations, particularly through the modulation of dietary components and microbial communities.

References

• [1] Saeedi Saravi, S. S., et al. (2025). Gut microbiota-dependent increase in phenylacetic acid induces endothelial cell senescence during aging. Nature Aging, 10.1038/s43587-025-00864-8.
• [2] Donato, A. J., et al. (2018). Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease. Circulation Research, 123(7), 825–848.
• [3] Han, Y., & Kim, S. Y. (2023). Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics. Experimental & Molecular Medicine, 55(1), 1–12.
• [4] Zhu, Y., et al. (2023). Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. Cell Host & Microbe, 31(1), 18–32.e9.
• [10] Marques, F. Z., et al. (2017). High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice. Circulation, 135(10), 964–977.